Embecta (EMBC) Net Income towards Common Stockholders (QoQ) (2021 - 2026)
Embecta (EMBC) Net Income towards Common Stockholders (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Embecta | 204.88 Mn | 11.48 Mn | 127.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.30% |
| Dec 31, 2025 | 67.05% |
| Sep 30, 2025 | -41.98% |
| Jun 30, 2025 | 93.62% |
| Sep 30, 2024 | -0.68% |
| Jun 30, 2024 | -49.13% |
| Mar 31, 2024 | 43.78% |
| Dec 31, 2023 | 235.00% |
| Sep 30, 2023 | -60.53% |
| Jun 30, 2023 | 8.57% |
| Mar 31, 2023 | -60.23% |
| Dec 31, 2022 | 304.65% |
| Sep 30, 2022 | -127.56% |
| Jun 30, 2022 | -21.61% |
| Mar 31, 2022 | -19.43% |
| Dec 31, 2021 | 1.96% |
| Sep 30, 2021 | -7.45% |
| Jun 30, 2021 | -2.97% |
| Mar 31, 2021 | 2.47% |